EyePoint Pharmaceuticals Inc. (EYPT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    EyePoint Pharmaceuticals ...

    NASDAQ: EYPT · Real-Time Price · USD
    13.90
    0.71 (5.38%)
    At close: Sep 26, 2025, 3:59 PM

    EyePoint Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 99.7M 281.26M 95.63M 178.59M
    Short-Term Investments
    		 271.21M 49.79M 48.93M 32.97M
    Long-Term Investments
    		 n/a 150K 150K 150K
    Other Long-Term Assets
    		 5.98M n/a 1.36M 626K
    Receivables
    		 607K 805K 15.5M 18.35M
    Inventory
    		 2.31M 3.91M 2.89M 3.62M
    Other Current Assets
    		 1.41M 1.01M 9.86M 4.22M
    Total Current Assets
    		 383.31M 344.8M 172.81M 237.75M
    Property-Plant & Equipment
    		 29.18M 10.23M 6.04M 2.25M
    Goodwill & Intangibles
    		 n/a n/a n/a 22.75M
    Total Long-Term Assets
    		 35.16M 10.38M 7.55M 25.63M
    Total Assets
    		 418.46M 355.18M 180.36M 263.37M
    Account Payables
    		 11.72M 6.5M 5.92M 7.38M
    Deferred Revenue
    		 17.78M 38.59M 1.21M 1.07M
    Short-Term Debt
    		 n/a n/a 10.47M n/a
    Other Current Liabilities
    		 13.27M 5.54M 6.09M 5.58M
    Total Current Liabilities
    		 49.05M 63.26M 34.54M 23.66M
    Long-Term Debt
    		 n/a n/a 29.31M 36.56M
    Other Long-Term Liabilities
    		 205K n/a 600K 2.35M
    Total Long-Term Liabilities
    		 32.92M 25.6M 49.45M 55.33M
    Total Liabilities
    		 81.96M 88.86M 83.99M 78.99M
    Total Debt
    		 21.86M 4.91M 45.77M 38.42M
    Book Value
    		 336.5M 266.32M 96.37M 184.38M
    Book Value Per Share
    		 5.98 6.85 2.58 6.41
    Common Stock
    		 68K 49K 766.93M 752.64M
    Retained Earnings
    		 -873.02M -742.15M -671.35M -569.1M
    Comprehensive Income
    		 1.03M 864K 786K 841K
    Shareholders Equity
    		 336.5M 266.32M 96.37M 184.38M
    Total Investments
    		 271.21M 49.94M 48.93M 32.97M

    Add to Watchlist